Chair of FDA review committee for Kymriah, the first CAR-T BLA.

10 years of FDA cellular and gene therapy review experience.

7 years of R&D experience at VIRxSYS Corp.

Postdoctorate at UCSF.

Ph.D. from State University of New York.

US based.

Victor Xiaobin Lu, Ph.D.

CTO